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Abstract
Major depression is the most common psychiatric diagnosis in Human 
Immunodeficiency Virus (HIV). However a few studies have focused 
on clinical depression as a risk factor for HIV infection. There are 
evidences to show that individuals with depressive symptoms can be 
predisposed to diseases such as HIV infection. Literature point out that 
the negative influence of depression as a risk factor for HIV can be 
explained because physical deterioration or depression can result in 
fatigue, physical impairment, and loss of motivation and self-confiden-
ce to engage in food and income generating activity. Other authors 
point out that this increased risk is thought to be due to high rates of 
substance use including injection drug use (IDU), risky sexual behavior, 
sexual victimization, and prostitution. It´s consensus that are needed 
social support for HIV-infected patients that includes treatment for 
depression and substance abuse. Screening of depression should also 
be conducted regularly to provide a full psychiatric profile to decrease 
the risk of depression and improve quality of life in this population.
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Epidemiology
Major depressive disorder is a chronic and disabling mental illness [1], 
worldwide the fourth leading illness causing functional disability [2, 
3], associated with increased mortality and shortened lifespan [4, 5]. 
In 2011, it was estimated that more than 1.1 million people were 
living with HIV/AIDS and 50,000 people were newly diagnosed 
with HIV in the United States [6]. According to the World Health 
Organization and United Nations Program on HIV/ AIDS (UNAIDS), 
35.3 million people were HIV positive at the end of 2012, with 2.3 
million new infections per year and 1.3 million deaths per year due 
to AIDS [7]. 
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Major depression is the most common psychiatric 
diagnosis in Human Immunodeficiency Virus (HIV) 
with incidence rates estimated from 5% and 42% 
up to 20% across the lifespan [8]. In a large natio-
nally representative probability sample of persons 
living with HIV in the USA, 37% screened positive 
for depression using a self-report [9, 10]. In Sub-
Saharian Africa the prevalence of around 8% [11]. 
HIV-positive individuals are at a twofold to fivefold 
greater risk for depression than are HIV-negative 
individuals [12]. However, from a review of the cu-
rrent literature, it appeared that a few studies have 
focused on clinical depression as a risk factor for 
HIV infection. Most of the researches, in fact, have 
assessed depressive symptoms in patients who have 
already received HIV diagnosis [13].
Depression as a risk factor for HIV
There are evidence to show that individual with de-
pressive symptoms can be predisposed to diseases 
such as HIV infection [14], diabetes, and even death 
from suicide [15, 16]. 
In multivariable models, individuals reporting 
schizophrenia (adjusted prevalence ratio = 1.68, 
95% confidence interval = 1.33-2.13), bipolar disea-
se (1.58, 1.39-1.81), and depression and/or anxie-
ty (1.31, 1.25-1.38) were more likely to be tested 
for HIV than persons without these diagnoses [17]. 
Wu et al [18] tried to identify vulnerable subgroups 
within the severely mentally ill population at eleva-
ted risk for HIV infection, administering the Colo-
rado Symptom Index to 228 HIV positive and 281 
HIV-negative subjects. The authors have found that 
a tool score ≥30 was associated with a 47 % in-
creased risk for HIV infection.
Among 61,128 participants of the 2008 Behavio-
ral Risk Factor Surveillance System survey, 65 years 
of age who responded to the question about HIV 
risk behaviors, 1,475 (3.4% of weighted sample) 
reported they had one or more such behaviors in 
the preceding year. For male respondents, the pre-
valence of current major depression was 6.1% (95% 
CI: 3.9, 9.5) among 637 who reported having one 
or more HIV risk behaviors and 3.0% (95% CI: 2.6, 
3.4) among 23,142 who did not report having such 
behaviors (p = 0.03) [19]. Vujanovic et al [20] re-
ports a series of hierarchical and logistic regression 
analyses was conducted and Depressive symptoms 
were significantly incrementally associated with wo-
rry about HIV infection.
Depression as a promoter of risk behavior 
for HIV
In the context of HIV, the negative influence of de-
pression as a risk factor can be explained because 
physical deterioration or depression can result in fa-
tigue, physical impairment, and loss of motivation 
and self-confidence to engage in food and income 
generating activity [21]. For other authors [22, 23] 
this increased risk is thought to be due to high ra-
tes of substance use including injection drug use 
(IDU), risky sexual behavior, sexual victimization, and 
prostitution. 
On sexual risk behavior, there is evidence that 
rates of unprotected sex are higher among women 
than men – respectively, 56% and 43% of patients 
with severe mental illnesses in the last three months 
in the USA [24]. Gender-based inequalities, inclu-
ding cultural values (e.g., men should have many 
partners, women should be monogamous), so-
cioeconomic context (e.g. unequal access to educa-
tion, employment, increased violence, and restricted 
reproductive rights among women) which potentia-
lly place women at a disadvantage for negotiating 
safer sex or refusing unwanted sex, can partially 
explain differential rates of unprotected sex repor-
ted among men and women [25]. 
The findings of Tsai et al [26] suggest that forced 
sex is associated with adverse mental health outco-
mes among HIV-positive women in rural Uganda. 
The authors show in multivariable analyses that 
victimization was associated with greater depres-
sion symptom severity (b = 0.17; 95% CI = [0.02, 
0.33]) and lower mental health–related quality of 
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life (b = −5.65; 95% CI = [−9.34, −1.96]), as well 
as increased risks for probable depression (adjusted 
relative risk [ARR] = 1.58; 95% CI = [1.01, 2.49) 
and heavy drinking (ARR = 3.99; 95% CI = [1.84, 
8.63]). For Nuttbrock et al [27], examined gender 
abuse and depressive symptoms as risk factors for 
HIV and other sexually transmitted infections (HIV/
STI) among male-to-female transgender persons 
(MTFs), the psychological vulnerability of younger 
MTFs to gender abuse apparently causes them to 
engage in high-risk sexual behavior and ultimately 
become HIV/STI infected.
Brandt et al [28] show that there was a signifi-
cant interaction between depressive symptoms and 
emotion dysregulation in relation to HIV symptoms, 
HIV medication adherence due to medication side 
effects, avoidant coping, and distress tolerance. The 
form of the interaction indicated that patients live 
with HIV experiencing higher depressive symptoms 
and higher levels of emotion dysregulation repor-
ted the highest levels of HIV symptoms and lowest 
levels of distress tolerance. Additionally, results indi-
cated that at lower levels of depressive symptoms, 
very high levels of emotion dysregulation predicted 
higher rates of medication nonadherence, whereas 
at higher levels of depressive symptoms, very high 
levels of emotion dysregulation predicted the lowest 
rates of medication nonadherence.
Higher counts of activated T cells were associa-
ted with fewer depression symptoms measured 12 
months later in adjusted analysis in cohort [29]. 
These finding may be related to the fact that ini-
tiation of depression treatment is associated with 
better ART adherence in persons living with HIV/
AIDS [30]. Recent meta-analysis across 95 samples 
found depressive symptoms were significantly rela-
ted to ART nonadherence [31]. Patients who drop-
ped out of ART for ≥12 months (Lost-to-Care, LTCs) 
had higher viral loads and depression, lower CD4+ 
counts, more alcohol, heroin, and injection drug use 
in the past 30 days [32]. On the other hand, persons 
with HIV and mental illness may be at risk for poor 
treatment adherence, development of treatment-
resistant virus, and worse outcomes [33]. 
Conclusion
Therefore, the increased risk for HIV infections 
among persons with serve mental illness and the 
disproportionate burden of disease it represents 
for these people require more attention and more 
effective individualized treatments [23], since de-
pression has a significant negative impact for HIV-
infected patients, reducing their adherence to ART 
treatment, quality of life, treatment outcome, and 
functionality. In addition to hastening HIV disease 
progression and mortality, depression further may 
facilitate viral transmission contributing to a cycle 
of reinforcement between depression and HIV ill-
ness [13]. Thus, screening of depression should be 
conducted regularly to provide a full psychiatric 
profile to decrease the risk of depression and im-
prove quality of life in this population [34]. Social 
support for HIV-infected patients that includes 
treatment for depression and substance abuse is 
likely to pay dividends in the form of lower non-
AIDS mortality [35].
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